Beta Drugs Limited (NSE:BETA)
2,366.80
+176.50 (8.06%)
At close: Jul 10, 2026
34.17% (1Y)
| Market Cap | 23.89B +34.3% |
| Revenue (ttm) | 3.85B +6.2% |
| Net Income | 414.83M -2.2% |
| EPS | 40.92 -2.6% |
| Shares Out | 10.09M |
| PE Ratio | 57.84 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 95,317 |
| Open | 2,190.30 |
| Previous Close | 2,190.30 |
| Day's Range | 2,190.30 - 2,395.00 |
| 52-Week Range | 990.10 - 2,395.00 |
| Beta | -0.52 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |